SWM
ABBV icon

Sterling Wealth Management’s AbbVie ABBV Stock Holding History

Sterling Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764K Buy
3,035
+2
+0.1% +$430 0.19% 55
2026
Q1 		$660K Buy
3,033
+2
+0.1% +$444 0.18% 52
2025
Q4 		$693K Buy
3,031
+149
+5% +$33.9K 0.2% 50
2025
Q3 		$667K Buy
2,882
+2
+0.1% +$407 0.2% 52
2025
Q2 		$535K Buy
+2,880
New +$535K 0.18% 55
2024
Q4 		$527K Buy
2,967
+1
+0% +$184 0.19% 57
2024
Q3 		$586K Buy
2,966
+2
+0.1% +$373 0.22% 56
2024
Q2 		$508K Buy
2,964
+114
+4% +$18.9K 0.24% 54
2024
Q1 		$519K Buy
2,850
+2
+0.1% +$345 0.26% 51
2023
Q4 		$441K Buy
+2,848
New +$415K 0.25% 56

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sterling Wealth Management's ABBV Position: Q2 2026 in Review

Sterling Wealth Management increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $430 and bringing the position to 3,035 shares worth $764K. The position accounts for 0.19% of the portfolio, ranked #55.

Sterling Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sterling Wealth Management held 3,035 shares of AbbVie worth $764K as of Q2 2026.
  • Sterling Wealth Management bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.19% of Sterling Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Sterling Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sterling Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.